DRKS00012480招募中4 期
Treatment Of Gastrointestinal Bleeding With PuraStat® - Prospective Multicenter-Pilotstudy For The Use of Purastat® for GI-Bleeding - PuraStat®
Charité Campus Benjamin Franklin0 个研究点目标入组 97 人开始时间: 2017年7月13日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 97
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years(—)
- 性别
- All
入选标准
- •Inclusion criteria were:
- •All gastrointestinal bleedings between Forrest Ib-IIc and lower, large-area bleedings, diffuse bleedings.
- •Subgroup for Forrest Ia bleeding (decision of the treating physician), signed consent of the patients if possible, patients between 18-80 years
排除标准
- •Forrest IA-bleedings should be treated conventionally. If the physician recognized an indication for the use of PuraStat® in Forrest IA-bleeding these patients were analyzed as a subgroup
研究者
相似试验
尚未招募
不适用
Early Diagnosis of Acute Gastrointestinal Bleeding with PillCam ESOGastrointestinal BleedingOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12609000580279Given Imaging Inc100
进行中(未招募)
不适用
Comparing mortality rate in non-variceal upper gastrointestinal hemorrhage patient visiting phramongkutklao hospital between weekend and weekdayppergastrointestinal hemorrhageUppergastrointestinal hemorrhageTCTR20171013003Phramongkutklao hospital500
已完成
4 期
Gastrointestinal bleeding complicating antiplatelet treatment after percutaneous coronary intervention(PCI)patients for indicated antiplatelet treatment after percutaneous coronary intervention(PCI)JPRN-UMIN000001610Graduate School of Medicine Science, Kumamoto University240
Unknown
4 期
Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic HemoclipUpper Gastrointestinal BleedingNCT02537353University of Sao Paulo General Hospital40
进行中(未招募)
1 期
Reduction of bleeding during abdominal plastids with Exacyl®EUCTR2018-000411-24-FRCHRU de Brest442
